跳至主要内容
临床试验/NCT00569517
NCT00569517已完成不适用

The Effect of Brief Group Cognitive Behavioral Therapy on Decreasing Metabolic Syndrome Risk Factors in Obese Patients Treated With Atypical Antipsychotics

US Department of Veterans Affairs2 个研究点 分布在 1 个国家目标入组 32 人开始时间: 2008年1月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
32
试验地点
2
主要终点
The accessibility to overweight outpatients with stable psychotic or mood disorders, currently treated with atypical antipsychotics willing to participate in a research study involving CBT.

研究概览

简要总结

The purpose of this pilot study is to assess patient accessibility, interest and response in order to design an adequately powered study to compare brief, group cognitive behavioral therapy (CBT) for weight loss to usual care in non-demented patients above the age of 18 years old who are currently taking atypical antipsychotic medications. This pilot study is necessary, with current limitations of data in this area, to design an adequately powered study to address the difficulties managing metabolic syndrome risk factors in patients on antipsychotics.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 18 years and above
  • Patients with diagnosis of schizophrenia, schizoaffective disorder or bipolar disorder determined by assessment with chart review, currently taking at least one atypical antipsychotic, started at least 2 months prior to randomization
  • Body Mass Index (BMI) greater than 30
  • ability to consent to treatment, determined by the patient's treating/referring physician

排除标准

  • Patients with premorbid medical problems that preclude involvement in a weight loss program
  • Active substance abuse or dependence, indicated by a positive urine drug screen in the last 3 months
  • Mini- Mental Status Exam (MMSE) less than 24
  • active psychosis or mania, determined by administration of the PANSS score greater than 3 on the following items; delusions, conceptual disorganization, hallucinatory behavior, blunted affect, social withdrawal, lack of spontaneity and conversation flow, mannerisms and posturing, and unusual thought content, and YMRS greater than 10, respectively
  • active major depressive episode, determined by administration of HAM-D greater than 13
  • patients taking any medications for weight loss or currently enrolled in a weight loss program
  • changes in medication regimen for diabetes or dyslipidemia within the last 3 months

结局指标

主要结局

The accessibility to overweight outpatients with stable psychotic or mood disorders, currently treated with atypical antipsychotics willing to participate in a research study involving CBT.

时间窗: 3 months

次要结局

  • Measure outcome parameters; body mass index, total cholesterol, low-density lipoproteins, triglycerides, fasting blood sugar, waist circumference, blood pressure & pulse among patients receiving CBT treatment or usual care at baseline, 6 wks & 12 wks.(3 months)

研究者

申办方类型
Fed

研究点 (2)

Loading locations...

相似试验